Literature DB >> 6129489

L-carnitine for methylmalonicaciduria.

D W Seccombe, F Snyder, H G Parsons.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129489     DOI: 10.1016/s0140-6736(82)91300-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Inhibition of oxidative metabolism by propionic acid and its reversal by carnitine in isolated rat hepatocytes.

Authors:  E P Brass; P V Fennessey; L V Miller
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

2.  Carnitine metabolism and inborn errors.

Authors:  A G Engel; C J Rebouche
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

Review 3.  l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors:  K L Goa; R N Brogden
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

4.  Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.

Authors:  E P Brass; R A Beyerinck
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

5.  Neonatal citrullinaemia with satisfactory mental development.

Authors:  P Sanjurjo; J Rodríguez-Soriano; A Vallo; A Arranz; V Rubio
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

6.  The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia.

Authors:  H Böhles; W Lehnert
Journal:  Eur J Pediatr       Date:  1984-11       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.